-
CSL Seqirus prepared to deliver 2024/25 U.S. season influenza vaccine portfolio
The vaccine portfolio is based on the trivalent strains recommended by the FDA's Vaccines and Related Biological Products Advisory Committee. -
VaxServe's Kevin Carrozza talks about what's new in vaccines and how the company is helping grow retail immunizations
Kevin Carrozza talks about the company’s history and what they are doing to help retail pharmacies expand immunizations.Sponsored